The following charges will be included in contract budgets for industry funded studies (funded by drug or device manufacturers or other for-profit sponsors) for contracts managed by RFMH or Columbia:
$3,000 for initial review, $500 each for sponsor initiated amendments, $500 each for continuing reviews. The fee applies regardless of whether a convened meeting or expedited IRB review (including expedited review conducted by subcommittee) is involved.
• IRB fees must be included in study budgets before submission to the RFMH, Columbia, or outside business offices, as applicable.
• Fees will be applied to all commercially supported human subjects research regardless of whether the research is industry sponsored (“industry written”) or investigator initiated.
To see the full RFMH policy, please visit the RFMH website at http://corporate.rfmh.org/grants/forms/standard_IRB_fees.pdf